Artboard 33atençãoArtboard 18atualizarconectividadeArtboard 42boletocarrinhocartãoArtboard 45cartão SaraivacelularArtboard 42Artboard 23checkArtboard 28Artboard 17?compararcompartilharcompartilhar ativoArtboard 28Artboard 43Artboard 49Artboard 47Artboard 15Artboard 32ebookArtboard 22Artboard 5Artboard 25Artboard 1Artboard 42Artboard 11fecharfilmesArtboard 23gamesArtboard 4Artboard 9Artboard 6hqimportadosinformáticaArtboard 7Artboard 3Artboard 12Artboard 25Artboard 34Artboard 43Artboard 44curtirArtboard 24Artboard 13livrosArtboard 24Artboard 31menumúsicaArtboard 27Artboard 30Artboard 36Artboard 44outrospapelariaArtboard 17Artboard 6Artboard 27Artboard 30Artboard 29Artboard 26Artboard 2Artboard 20Artboard 35estrelaestrela ativorelógiobuscaArtboard 50Artboard 26toda saraivaArtboard 40Artboard 21Artboard 10Artboard 37usuárioArtboard 46Artboard 33Artboard 8seta
e-book

Biosimilars and Interchangeable Biologics - Strategic Elements (Cód: 9533735)

Niazi,Sarfaraz K.

Taylor & Francis (Livros Digitais)

Ooops! Este produto não está mais a venda.
Mas não se preocupe, temos uma versão atualizada para você.

Ooopss! Este produto está fora de linha, mas temos outras opções para você.
Veja nossas sugestões abaixo!

R$ 284,85

em até 9x de R$ 31,65 sem juros

Total:

Em até 1x sem juros de


Crédito:
Boleto:
Cartão Saraiva:

Total:

Em até 9x sem juros de


Biosimilars and Interchangeable Biologics - Strategic Elements

R$284,85

Descrição

What'apos;s the Deal with Biosimilars?
Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development.
Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets.
Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current status of the art and science of biosimilars, and it provides detailed descriptions of the legal, regulatory, and commercial characteristics. The book also presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle.

Características

Produto sob encomenda Não
Marca Taylor & Francis (Livros Digitais)
Cód. Barras 9781498743488
Acabamento e-book
Início da Venda 05/01/2016
Territorialidade Internacional
Formato Livro Digital Pdf
Gratuito Não
Tamanho do Arquivo 12002
Proteção Drm Sim
Idioma 337
Código do Formato Pdf
Número de Páginas 599 (aproximado)
Ano da Publicação 2016
Peso 0.00 Kg
AutorNiazi,Sarfaraz K.